Takeaway: We are removing Valvoline long from Investing Ideas

A quick note from Hedgeye CEO Keith McCullough:

This is the same top-down macro market timing reason as Tenet Healthcare (THC). In addition to HIGH BETA, SMALL CAP is a Factor Exposure The Machine will not like being long of during #Quad4 in Q3 EPS #slowing season.

*There is no change to Retail analyst Brian McGough's fundamental long thesis on Valvoline (VVV).